Welcome to our dedicated page for PETVIVO HOLDINGS news (Ticker: PETV), a resource for investors and traders seeking the latest updates and insights on PETVIVO HOLDINGS stock.
PetVivo Holdings Inc (PETV) is an emerging biomedical device company with a focus on licensing and commercializing innovative medical devices for pets, known as pet therapeutics. The company aims to capitalize on investments in the human biomaterials and medical device industries to bring therapeutics to pets efficiently. As part of its strategy, PetVivo in-licenses proprietary products from human medical device companies for pet use. Its wholly-owned subsidiaries include PetVivo, Inc., Gel-Del Technologies, Inc., and CosmetaLife Corporation.
Rhea-AI Summary
PetVivo Holdings, Inc. received positive response for its innovative product Spryng™ with OsteoCushion™ technology at the ACVS conference. Two presentations and a clinical study demonstrated the benefits and tolerability of Spryng™ in managing joint-related afflictions in companion animals. The study showed significant improvements in pain, lameness, and quality of life scoring. Spryng™ is a non-invasive alternative for patients with cranial cruciate disease when surgery is not an option.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.63%
Tags
-
Rhea-AI Summary
PetVivo Holdings, Inc. to release results of clinical study at ACVS annual conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.31%
Tags
-
Rhea-AI Summary
PetVivo Holdings, Inc. to exhibit at ACVS conference and showcase Spryng™ with OsteoCushion™ Technology
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.71%
Tags
Rhea-AI Summary
PetVivo Holdings, Inc. to present at The ThinkEquity Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
-
Rhea-AI Summary
PetVivo Holdings, Inc. to present at H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
-
Rhea-AI Summary
PetVivo achieves milestone with sale of Spryng to over 500 veterinary clinics in 49 states
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
Rhea-AI Summary
PetVivo Holdings, Inc. has received a notice of allowance from the USPTO for a patent application related to its biocompatible protein-based particles. The patent provides comprehensive coverage for a range of proprietary products, including the sponge-like particles used in PetVivo's signature product, Spryng™ with OsteoCushion™ Technology. PetVivo's intellectual property portfolio now consists of twenty allowed patents, with ten being United States patents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.24%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
News
Rhea-AI Summary
PetVivo Holdings, Inc. is approaching a milestone of selling its signature product to its 500th veterinary clinic. The company has supplied the product to over 450 clinics in 47 states, reflecting its increasing presence across the country.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.39%
Tags
FAQ
What is the current stock price of PETVIVO HOLDINGS (PETV)?
The current stock price of PETVIVO HOLDINGS (PETV) is $0.5799 as of December 26, 2024.
What is the market cap of PETVIVO HOLDINGS (PETV)?
The market cap of PETVIVO HOLDINGS (PETV) is approximately 9.2M.
What is PetVivo Holdings Inc's focus?
PetVivo Holdings Inc focuses on licensing and commercializing innovative medical devices for pets, known as pet therapeutics.
How does PetVivo leverage investments in other industries?
PetVivo leverages investments in the human biomaterials and medical device industries to efficiently bring therapeutics to pets.
What is PetVivo's strategy regarding proprietary products?
PetVivo in-licenses proprietary products from human medical device companies specifically for use in pets.
What are the wholly-owned subsidiaries of PetVivo Holdings Inc?
PetVivo Holdings Inc's wholly-owned subsidiaries include PetVivo, Inc., Gel-Del Technologies, Inc., and CosmetaLife Corporation.
What is the goal of PetVivo Holdings Inc?
The goal of PetVivo Holdings Inc is to commercialize therapeutics for pets in a capital and time-efficient manner.
What industry does PetVivo Holdings Inc operate in?
PetVivo Holdings Inc operates in the biomedical device industry with a focus on pet therapeutics.
How does PetVivo Holdings Inc differentiate itself in the market?
PetVivo Holdings Inc differentiates itself by focusing on innovative medical devices for pets and leveraging investments in related industries.
Where is PetVivo Holdings Inc headquartered?
PetVivo Holdings Inc is headquartered in the United States.
What is the relationship between PetVivo Holdings Inc and Gel-Del Technologies, Inc?
Gel-Del Technologies, Inc is a wholly-owned subsidiary of PetVivo Holdings Inc.
What is the significance of CosmetaLife Corporation to PetVivo Holdings Inc?
CosmetaLife Corporation is a wholly-owned subsidiary of PetVivo Holdings Inc, playing a role in the company's operations.
PETVIVO HOLDINGS INC